⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALT News
Altimmune, Inc. Common Stock
Form 8-K
sec.gov
ALT
Form 8-K
sec.gov
ALT
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
globenewswire.com
ALT
PTHS
Altimmune to Present New Data on Pemvidutide in Serious Liver Diseases at AASLD The Liver Meeting® 2026
globenewswire.com
ALT
Substance Use Disorder (SUD) Drug Pipeline Analysis Report 2026 | 100+ Drug Candidates, Phase II Dominance, and Long-Acting Therapies Signal Strategic Investment Opportunities
globenewswire.com
LLY
BG
ALKS
ALT
Form 8-K
sec.gov
ALT
TMO
Altimmune to Participate in Stifel Cardiometabolic Forum
globenewswire.com
ALT
Metabolic Dysfunction-Associated Steatohepatitis Competitive Landscape and Clinical Trial Analysis Report 2026 Assesses 180+ Companies and 200+ Drugs
globenewswire.com
MDGL
NVO
GSK
ALT
GALT
VKTX
CRBP
CANF
BILI
MRK
Hypertension Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
BNTX
ASO
IONS
BIIB
ALT
TEVA
TENX
UTHR
PFE
UNH
ABBV
GOSS
INSM
Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference
globenewswire.com
ALT